Beranda › Kerdil Hipofisis › Texas
Uji klinis Kerdil Hipofisis di Texas
6 studi untuk Kerdil Hipofisis mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
- Lumos Pharma Investigational Site, Amarillo
- Lumos Pharma Investigational Site, Corpus Christi
- Lumos Pharma Investigational Site, Fort Worth
- dan 1 lainnya
Menerima pesertaFase 3
Usia 3 hingga 11 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06948214Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
- South Texas Health Care System, San Antonio, TX, San Antonio
Menerima pesertaFase 3
Usia 21 hingga 55 · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT04867317Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
- Michael E. DeBakey VA Medical Center, Houston
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT05355272A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
- Ascendis Investigational Site, Dallas
- Ascendis Investigational Site, El Paso
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT05820672A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
- Ascendis Investigational Site, Dallas
- Ascendis Investigational Site, El Paso
Menerima pesertaStudi observasional
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT05775523Chromosome 18 Clinical Research Center
- University Health Systems Hospital, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 6 Jan 2026 · NCT00227253Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.